Chronic Plaque Psoriasis (Ps) Registry

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00237887 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

NCT02581345 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

NCT01970488 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

NCT04453137 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00645814 ·Status: COMPLETED ·Phase: PHASE2

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

NCT05073315 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02850965 ·Status: COMPLETED ·Phase: PHASE3

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT05495568 ·Status: COMPLETED ·Phase: PHASE3

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis

NCT00513370 ·Status: COMPLETED ·Phase: PHASE3

HUmira in Psoriatic Arthritis

NCT01465438 ·Status: COMPLETED ·Phase: PHASE4

Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab

NCT01077128 ·Status: COMPLETED

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00645905 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life

NCT01169987 ·Status: COMPLETED

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

NCT03104400 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT05510063 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

NCT01401452 ·Status: COMPLETED

Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

NCT01872546 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00646191 ·Status: COMPLETED ·Phase: PHASE2

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

NCT01265823 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

NCT01202565 ·Status: COMPLETED

Assessment of Long-Term Infliximab for Psoriasis (P05319)

NCT00779675 ·Status: COMPLETED

A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis

NCT04758117 ·Status: COMPLETED

Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

NCT02147600 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00195676 ·Status: COMPLETED ·Phase: PHASE3